Assessment of the safety and efficacy of dabigatran etexilate (Pradaxa®) in the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and the prevention of recurrent DVT and PE | boehringer-ingelheim.pt
Skip to main content